GSK

GlaxoSmithKline is a provider of medicines, vaccines and other health care products in the United States. The company serves the needs of clients in the health care industry. It deals in the research of various medicines and vaccines diseases, such as HIV/AIDS, tuberculosis and malaria. GlaxoSmithKline offers a range of drugs, such as salmeterol, fluticasone propionate, fondaparinux sodium, rosiglitazone maleate and glimepiride, and abacavir sulfate and lamivudine. The company provides products from the Advair, Augmentin, Lanoxin, Leukeran and Lexiva brands. It also provides the Abreva over-the-counter cold sore medicine. In addition, GlaxoSmithKline offers medicines for problems, such as Insomnia, headaches and dry lips. In addition, it is a part of GlaxoSmithKline plc.

GSK is a leading pharmaceutical company based in Durham that brings together science, technology, and talent to proactively combat diseases. Their innovative approach focuses on collaboration and unity to stay ahead in the fight against various health challenges. With a strong emphasis on research and development, GSK is dedicated to creating effective solutions that improve global health outcomes. By leveraging their expertise and resources, GSK strives to make a positive impact on the world through cutting-edge advancements in healthcare. Generated from their website's infomation

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that treat cancer, cardiovascular and autoimmune diseases and viral infections. BioCryst uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry and computer modeling. In structure-based drug design, scientists use detailed knowledge of the active sites of protein targets associated with particular diseases to design synthetic compounds that fight the disease. Structure-based drug design aims to create a molecule that will bind to the active site of a targeted enzyme, thereby preventing the normal chemical reaction and ultimately halting the progression of the disease. BioCryst was founded in 1986. The Company's stock is traded on the NASDAQ exchange under the symbol BCRX.